NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 292 filers reported holding NOVOCURE LTD in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,461 | -99.8% | 462 | -99.4% | 0.00% | -99.7% |
| Q2 2023 | $3,194,172 | +0.8% | 76,968 | +46.1% | 0.34% | -8.4% |
| Q1 2023 | $3,167,514 | -14.2% | 52,669 | +4.6% | 0.37% | -18.5% |
| Q4 2022 | $3,693,466 | +28311.3% | 50,354 | +29346.8% | 0.46% | +22650.0% |
| Q3 2022 | $13,000 | +333.3% | 171 | +271.7% | 0.00% | – |
| Q2 2022 | $3,000 | -25.0% | 46 | -9.8% | 0.00% | -100.0% |
| Q1 2022 | $4,000 | +300.0% | 51 | +410.0% | 0.00% | – |
| Q4 2021 | $1,000 | -90.0% | 10 | -88.9% | 0.00% | -100.0% |
| Q3 2021 | $10,000 | -68.8% | 90 | -37.1% | 0.00% | -57.1% |
| Q2 2021 | $32,000 | +88.2% | 143 | +10.0% | 0.01% | +75.0% |
| Q1 2021 | $17,000 | -5.6% | 130 | +23.8% | 0.00% | 0.0% |
| Q4 2020 | $18,000 | +63.6% | 105 | +5.0% | 0.00% | +33.3% |
| Q3 2020 | $11,000 | +175.0% | 100 | +33.3% | 0.00% | +200.0% |
| Q2 2020 | $4,000 | – | 75 | – | 0.00% | – |
| Q4 2018 | $0 | – | 0 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $29,071,000 | 12.94% |
| HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
| Deep Track Capital, LP | 1,000,000 | $82,850,000 | 5.31% |
| MORGAN JESS S & CO INC | 48,860 | $4,048,000 | 2.94% |
| Taylor Frigon Capital Management LLC | 73,014 | $6,049,000 | 2.24% |
| Private Harbour Investment Management & Counsel, LLC | 13,263 | $1,099,000 | 0.92% |
| HighVista Strategies LLC | 17,448 | $1,446,000 | 0.92% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $829,000 | 0.79% |
| Lloyd Park, LLC | 6,700 | $555,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 69,700 | $5,775,000 | 0.57% |